When did Kiniksa Pharmaceuticals International, plc report Q2 2025 earnings?

Kiniksa Pharmaceuticals International, plc (KNSA) reported Q2 2025 earnings on July 29, 2025 before market open.

What were Kiniksa Pharmaceuticals International, plc's Q2 2025 revenue and EPS?

Kiniksa Pharmaceuticals International, plc reported revenue of $156.8M and diluted EPS of $0.23 for Q2 2025.

Revenue missed the consensus estimate of $166.5M by $9.7M. EPS beat the consensus estimate of $0.18 by $0.05.

You can read the 10-Q periodic report (0001558370-25-009738) directly on SEC EDGAR. The filing index links above go to sec.gov.

Reported July 29, 2025 · Before market open

Revenue estimate$166.5M

EPS estimate$0.18

Jul 28, 2026 (in a month)

Revenue estimate$226.6M

EPS estimate$0.30

Q2 2025$156.8MMiss by $9.7M

Q2 2025$0.23Beat by $0.05

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did Kiniksa Pharmaceuticals International, plc report Q2 2025 earnings?: Kiniksa Pharmaceuticals International, plc (KNSA) reported Q2 2025 earnings on July 29, 2025 before market open.
What were Kiniksa Pharmaceuticals International, plc's Q2 2025 revenue and EPS?: Kiniksa Pharmaceuticals International, plc reported revenue of $156.8M and diluted EPS of $0.23 for Q2 2025.
Did Kiniksa Pharmaceuticals International, plc beat estimates in Q2 2025?: Revenue missed the consensus estimate of $166.5M by $9.7M. EPS beat the consensus estimate of $0.18 by $0.05.
Where can I find Kiniksa Pharmaceuticals International, plc's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001558370-25-009738) directly on SEC EDGAR. The filing index links above go to sec.gov.